3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Recruiting
6
Terminated
5
Completed
5
Unknown
2
Active not recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Conditions
Leukemia, Myeloid, Acute
38
Myelodysplastic Syndromes
14
Leukemia, Myelomonocytic, Chronic
10
Leukemia
4
Myeloproliferative Disorders
3
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
fludarabine
6
trametinib
5
Specimen Handling
5
Standard of Care
4
Practice Guidelines as Topic
4
Magnetic Resonance Spectroscopy
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Melphalan
3
Interviews as Topic
3
GSK2636771
3
Cyclophosphamide
3
Crizotinib
3
Busulfan
3
Biopsy
3
Antilymphocyte Serum
3
AP 1903 reagent
3
venetoclax
2
thymoglobulin
2
palbociclib
2
osimertinib
2
letermovir
2
dabrafenib
2
capivasertib
2
binimetinib
2
adavosertib
2
X-Rays
2
Thiotepa
2
Tacrolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Hematologic Neoplasms
×
Azacitidine
×
Clear all
NCT05428969
2026-04-23
BEXMAB
Faron Pharmaceuticals Ltd
Phase 1/2
Active not recruiting
181 enrolled
NCT04730258
2025-05-18
TWT-202
Treadwell Therapeutics, Inc
Phase 1/2
Active not recruiting
72 enrolled